ARCHIVES

New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors

March 6, 1992

Members of Congress say that won’t work.

September 30, 2005

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991